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doi:10.1016/j.ejvs.2011.05.017Abstract Objectives: We aimed to survey the current management of venous thrombopro-
phylaxis in patients undergoing elective surgery for abdominal aortic aneurysm (AAA) by
vascular surgeons in the United Kingdom.
Design: A questionnaire was designed to investigate anticoagulation strategies in the perio-
perative period of elective AAA repair, both open and endovascular. This included both chemi-
cal and mechanical prophylaxis. A total of 395 questionnaires was posted to the members of
the Vascular Society of Great Britain and Ireland.
Results: One hundred and seventy-two (44%) valid responses were received. Half of the
respondents administered pre-operative chemical prophylaxis at a mean of 13 h prior to AAA
surgery. There was a high level of concordance in administration of heparin during surgery
and in thromboprophylaxis post-operatively, with 97% giving some form of thromboprophylaxis.
However there was a variation in the dose and timing, if administered, of chemical and
mechanical prophylaxis.
Conclusion: The survey revealed diversity in perioperative thromboprophylaxis strategies
among vascular surgeons. This suggests that standardisation of pre-operative and post-
operative mechanical and chemical thromboprophylaxis may be required which could poten-
tially improve the outcomes in elective management of AAA in the UK.
ª 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.28 814149; fax: þ44 1228 814693.
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Abdominal aortic aneurysm surgery is being performed with
progressively lower operative mortality and morbidity
rates.1 The current mortality rate in the UK is 7% which is
nearly double the mortality rates in the rest of Europe.2
The proportion of patients dying from venous thromboem-
bolism (VTE) following AAA surgery is not known. The
reported incidence of DVT in aortic aneurysm surgery varies
from 2% to 24%.3e6 There are no set guidelines regarding
perioperative DVT prophylaxis, apart from use of heparin
during the actual aneurysm repair procedure.9 However
there are a few studies that have looked at the incidence of
DVT in AAA repair. The incidence of DVT in aortic surgery
was specifically addressed by several studies, three of
which were randomised.5,7,10 Killewich et al.5 reported an
incidence of 2% in both control and anti-coagulant groups,
while Belch et al.7 estimated a DVT incidence of 24% in the
control group. However, the latter study was not completed
because of significant haemorrhagic complications. Both
studies used ultrasound examination of legs post-opera-
tively to identify DVT. A Cochrane analysis of all non-
randomised prospective studies in aortic surgery identified
an average incidence of 9.2% among patients without DVT
prophylaxis.9 The incidence was 2.6% if calf DVT was
excluded. Although a reduced risk would be anticipated
after EVAR, the incidence of femoral or popliteal DVT after
endovascular repair was 6% among 50 patients examined by
Duplex ultrasonography.3 Consistent with these findings, de
Maistre et al.11 recently reported an incidence of lower
extremity DVT of 10.2% after surgical repair and 5.3% after
EVAR (P Z 0.28), despite prophylaxis with thigh-length
compression bandages or stockings, early mobilization,
and daily subcutaneous injection of low-molecular weight
heparin beginning in most patients within the first day after
open surgical repair or EVAR.
Therefore DVT after open AAA repair perhaps appears to
be underappreciated.3
The perceived low risk of DVT in aortic surgery has been
generally attributed to the routine use of intra-operativeTable 1 Pre-operative coagulation prophylaxis in AAA surgery.
Routinely initiate prophylaxis
Of those who apply pre-operative coagulation prophylaxis:
Drug/Dose/IU Heparin
Dalteparin
2500
5000
Enoxaparin
2000
4000
Tinzaparin
3500
4500
IU Z International Unit.heparin which is thought to be the peak time for any clot
formation.8,14
Our objective was to assess the current practice among
vascular surgeons on managing the risk of venous throm-
boembolism in patients undergoing elective surgery for
abdominal aortic aneurysm.
Methods
A self-reporting questionnaire was designed to determine
the common approaches in DVT prophylaxis, alike an earlier
survey.14 The questionnaire covered pre-operative initia-
tion, intra-operative and post-operative periods and looked
at both mechanical and chemical means of thrombopro-
phylaxes. It was mailed once without reminder to 395
practising UK members of the Vascular Society of Great
Britain and Ireland (VSGBI) in November 2010.
Further details included the types of agents used, their
dose and mode of administration. Responses were anony-
mous and the data was processed and analysed using the
Statistical Package for Social Sciences (SPSS) version 17.0
(SPSS Inc. Chicago, IL, USA, 2007).
Results
A total of 175 completed questionnaires were received back
in eight weeks, making a response rate of 44%. Three
surgeons returned it unfilled because they did not perform
major arterial surgeries.
The practice of VTE prophylaxis was analysed in pre-,
intra- and post-operative phases. Whilst half (50%) of the
respondents started patients on low-molecular weight
heparin (LMWH), there was wide variation at the time of
initiation prior to surgery. Eight surgeons reported admit-
ting patients on the day of surgery as the reason for not
initiating VTE prophylaxis pre-operatively. The majority
(69%) use enoxaparin and further details are shown in
Table 1. The majority of surgeons (48%) were found to
anticoagulate their patients 12 h prior to surgery (seeNumber of respondents (n Z 172)
n (%)
86 (50)
16 (19)
5 (31)
11 (69)
59 (69)
11 (19)
48 (81)
11 (13)
1 (9)
10 (91)
Figure 1 Time of initiation LMWH thromboprophylaxis
before surgery.
Figure 2 Time interval between IV heparin administration
and aortic cross clamping.
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surgery, 33 (19%) apply TEDS to patients prior to AAA
surgery.
Out of the 172 respondents, 164 (95%) reported that they
routinely administer heparin intravenously (IV) during
elective AAA open repair. 149 surgeons reported doing
elective AAA endovascular repair (EVAR) in their depart-
ment of whom 129 (87%) administer heparin during elective
EVAR. Out of the 164 surgeons who routinely administer
intravenous heparin during AAA open repair, 108 (74%) use
a fixed dose of 5000 IU while 38 (26%) alter the dose
according to body weight. Six surgeons did not specify the
heparin dose they use. In the case of EVAR, 98 surgeons out
of 129 (76%) use the 5000 IU dose open repair, with the
remaining surgeons using a different dose (see Table 2). The
majority of surgeons (97%) opt for the intravenous route, by
requesting the anaesthetist to administer the drug. Two
surgeons (1%) reported direct injection into the sac while
another 2 (1%) flushes the distal vessels by direct irrigation
of the common iliac arteries. One surgeon uses both the
intravenous and the distal flushing technique.
Fig. 2 shows the time interval between Heparin admin-
istration and aortic cross-clamping among the 164 surgeons
who administered heparin. Ninety-nine surgeons (68%) do
not reverse the heparin on completion of the procedure,
while 16 surgeons (11%) administer protamine routinely and
31 surgeons (21%) use reversal in cases with bleeding. Of
the 164 surgeons who routinely administered heparin duringTable 2 Coagulation prophylaxis during abdominal aortic aneur
Numb
Open
n (%)
Routinely administer IV Heparin during surgery 164 (
Dose/IU Heparin
2000 4 (
3000 20 (
3500 2 (
4000 6 (
5000 108 (
6000 2 (
7000 1 (
Not specified 3 (elective AAA open repair, 34 (21%) apply pneumatic calf
pumps during surgery. Similarly, out of the 146 surgeons
who routinely administer Heparin during elective EVAR, 19
(13%) apply pneumatic calf pumps during surgery.
Post-operatively, 167 (97%) respondents routinely
administered low-molecular weight heparin after surgery
(Table 3). All administered the LMWH via subcutaneous
route and first dose is administered at varying post-
operative intervals as illustrated in Fig. 3. Five surgeons
(3%) reported that they initiate Heparin at a variable time
depending on the coagulation status. Out of 149 surgeons,
141 (85%) discontinue heparin at discharge while the
remaining eight surgeons discontinue VTE prophylaxis 2e21
days after surgery. Mechanical prophylaxis is applied, by
means of thromboembolic deterrent (TED) stockings, prior
to surgery by 33 out of 172 (19%) surgeons, and this mode of
VTE prophylaxis rises to 85 out of 172 (49%) post-surgery.
Discussion
The survey reveals that there is a wide variation in the VTE
prophylaxis management by the vascular surgeons in the
UK. This is not confined to any particular phase of surgery.
In addition to the variation in the general principles of VTE
prophylaxis, details of management such as dosing, initia-
tion time, termination time and modality & time of appli-
cation of mechanical prophylaxis also vary widely. Albeit
a low response rate, the survey reveals that there isysm surgery.
er of respondents (n Z 172)
repair (n Z 164) Endovascular repair (n Z 150)
n (%)
95) 146 (85)
3) 1 (1)
14) 20 (15)
1) 2 (2)
4) 3 (2)
74) 98 (76)
1) 2 (2)
1) e
2) 3 (2)
Table 3 Post-operative coagulation prophylaxis in abdominal aortic aneurysm surgery.
Number of respondents (n Z 172)
n (%)
Routinely administer heparin after surgery 167 (97)
Drug/Dose/IU heparin
Dalteparin 32 (19)
2500 8 (25)
5000 24 (75)
Enoxaparin 110 (66)
2000 22 (20)
4000 88 (80)
Tinzaparin 23 (14)
3500 4 (17)
4500 20 (87)
Heparin sodium 1 (1)
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does not seem to be a selection bias related to this low
response rate because the distribution of practice reported
was relatively equal in pre-operative chemical prophylaxis
and post-operative mechanical prophylaxis. However we
accept that this cannot be confirmed without knowing what
the remaining surgeons would have reported. The study
however does reveal considerable variation in clinical
practice in this area.
Overall, most patients undergoing EVAR can be consid-
ered at moderate to high risk for DVT, given advanced age,
duration of surgery >45 min, and the increasing prevalence
of obesity.12
The VSGBI or Cochrane review does not provide any
recommendations in this area due shortage of good
evidence to support such recommendations. The Society of
Vascular Surgery recommends DVT prophylaxis consisting of
intermittent pneumatic compression and early ambulation
is recommended for all patients undergoing AAA repair or
EVAR.12 The Society also incorporate guidelines suggesting
patients at high risk (e.g. prior history of DVT/pulmonary
embolism [PE], obesity [BMI >25], limited mobility status,
malignancy) should receive either LMWH (enoxaparin 40 mg
SC once a day) or unfractionated heparin (5000 IU SC two or
three times a day) initiated within 24 h at the discretion of
the treating surgeon. If a high-risk patient has a history of
renal insufficiency, unfractionated heparin (5000 IU SC
twice a day) is preferred, which is also favoured for thoseFigure 3 Time of initiation LMWH thromboprophylaxis after
surgery.patients who have an epidural catheter.12 This is in contrast
to what is recommended in e.g. the summary of product
characteristics for enoxaparin, which states: “In patients
with a low to moderate risk of venous thromboembolism
the recommended dosage is 20 mg (2000 IU) once daily by
subcutaneous injection for 7e10 days, or until the risk of
thromboembolism has diminished. In patients with a higher
risk, such as in orthopaedic surgery, the dosage should be
40 mg (4000 IU) daily by subcutaneous injection with the
initial dose administered approximately 12 h before
surgery”.13
The reported incidence of DVT in orthopaedic proce-
dures such as after total knee arthroplasty (TKA) and total
hip arthroplasty (THA) without prophylaxis is 40%e84%17
and 40%e70%, proximal DVT 8%e24%17 and 10%–20%, clin-
ical DVT 7%e11% and 1%–3%, non-fatal symptomatic
pulmonary thromboembolism 1.2%e3% and 1%e2%, and
fatal pulmonary thromboembolism 0.1%e1.1% and 0.1%e1%
respectively.18e22
While the majority of surgeons who administer pre-op-
erative LMWH initiate the therapy approximately 13 h prior
to surgery, there are surgeons giving this within shorter
time frames. DVT is believed to start in the pre-operative
period especially from the time of induction and therefore
post-operative initiation may not be effective as demon-
strated by the study performed by de Maistre et al.11 It is
logical to think that though calf compression is effective in
preventing DVT while there is sluggish venous flow in the
perioperative period, its safety and effectiveness when the
inflow into the legs are markedly diminished as in aortic
surgery will need further study before recommendation.
In the light of evidence from various trials in different
surgery specialties, mechanical thromboprophylaxis is
possibly not applied optimally by vascular surgeons per-
forming AAA surgery. A Cochrane review of eight randomised
controlled trials highlighted that graduated compression
stockings alone, when applied before or on day of surgery
can significantly reduce the incidence of DVT from 26% to
13% as measured predominantly by I125 uptake. However,
the evidence was gathered from various types of surgery and
not all studies showed a reduction in DVTs.15 One prospec-
tive randomised trial on joint arthroplasty patients showed
no reduction in DVT incidence when stockings were used,
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before surgery.16
Compared to the pre-operative 50:50 split in treatment
preference, there is a general agreement with the neces-
sity of post-operative prophylaxis as 97% of repairs received
LMWH, mostly enoxaparin at 4000 IU subcutaneously.
However, further studies to look at the best practice in the
areas of both mechanical and chemical thromboprophylaxis
could potentially improve or give clarification on the likely
outcomes in elective aortic surgery.
Until all these questions are answered DVT prophylaxis
in vascular patients will continue to be guided by evidence
of prophylaxis gained from studies of general surgical
patients. Of the three phases of anticoagulation, the least
concordance is present for pre-operative anticoagulation
management whereas the majority of vascular surgeons
take a similar approach to intra- and post-operative venous
thromboprophylaxis.
There is variation in the management of VTE prophylaxis
in elective AAA surgery in the UK. This may be one area
needing more evidence-based practice to potentially
improve the outcomes from this surgery.
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